Home > Insider Trading > Filing (0000899243-21-007336)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1754068	Allovir Inc.	ALVR	Biological Products, (No Disgnostic Substances) (2836)	831971007

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1763026	M. Ann Leen	C/O Allovir, Inc. 139 Main Street, Suite 500 Cambridge MA 02142	Chief Scientific Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2021-02-18	300	$39.20	2,491,531	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2021-02-18	1,100	$40.44	2,490,431	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2021-02-18	1,300	$41.50	2,489,131	No	4	S	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	28,000	Direct

Footnotes

This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 2, 2020.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.94 to $39.34. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Shares held by the Ann M. Leen Management Trust, for which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $40.09 to $40.75. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $41.14 to $41.71. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.